Abstract
This study describes the successful synthesis of nitric oxide (NO)-releasing compounds with biodegradable and injectable properties and demonstrates that the kinetics of NO release vary according to the type of NO donor. The antimicrobial activity of NO-releasing compounds against three common periodontal pathogens, i.e., Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Actinomyces israelii, was investigated using a susceptibility assay. Human gingival fibroblasts were treated with NO-releasing compounds at the minimum concentrations required for bacterial growth and cytotoxicity was evaluated using the MTT cell proliferation assay. Our results suggest that NO-releasing compounds can be used topically to treat both gram-negative and gram-positive periodontal pathogens. Comparison of the antimicrobial activity and cytotoxicity assay results between the NO-releasing compounds revealed that an NO donor comprising a macromolecule without surface charge, a lower instantaneous NO concentration, and an adequate supply of NO were associated with a strong bactericidal effect and low cytotoxicity. NO-releasing compounds with these properties may be suitable for treatment of periodontitis.
Highlights
Antibacterial agents can be administered systemically or topically for control of infection in periodontal tissue
Antibiotics delivered topically can reach the base of the periodontal pockets, which act as a natural drug reservoir and allow antibacterial concentrations to be maintained for long enough to have an antimicrobial effect [3]
We investigated the bactericidal effect of Pluronic F68-branched polyethylenimine-NONOates (F68-branched polyethyleneimine (BPEI)-nitric oxide (NO)) on three periodontal pathogens, i.e., Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Actinomyces israelii
Summary
Antibacterial agents can be administered systemically or topically for control of infection in periodontal tissue. Systemic administration of antibiotics has been proven to be effective in suppressing progression of periodontitis [1]. Overuse of antibiotics can have systemic side effects and promote development of antibiotic-resistant pathogens, so periodontitis cannot be treated via the systemic route for extended periods [2]. Antibiotics delivered topically can reach the base of the periodontal pockets, which act as a natural drug reservoir and allow antibacterial concentrations to be maintained for long enough to have an antimicrobial effect [3].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.